Genomic Predictors of Tamoxifen Response in American Male Breast Cancer Patients
Reading Time: 3 minutesIntroduction Tamoxifen, a widely used selective estrogen receptor modulator (SERM), has been pivotal in the management of hormone receptor-positive breast cancer. While traditionally associated with female patients, the use of tamoxifen in American males with breast cancer is gaining attention. Understanding the genomic predictors of tamoxifen response can significantly enhance treatment outcomes. This article delves into the genetic factors influencing... Read more »
